A new study has answered a question that has puzzled cancer researchers for decades: Does a genetic defect found in nearly all human colorectal cancers simply accompany the disease, or does it trigger its development? A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center showed that replicating the genetic defect by deleting a single gene called COSMC (C1GalT1C1) in cells lining the intestines of mice led to the development of invasive colorectal cancer within a year.
AI Startup Red Queen Bio Uses Artificial Intelligence to Prepare for a Future Pandemic
Red Queen Bio is using AI to design antibody drugs against novel pathogens, highlighting the growing role of artificial intelligence in pandemic preparedness and biotech.


0 Comments